Ginkgo Bioworks Inc.

DNA | NYSE

Price Alert Chart Builder DCF Calculator

$7.98

+$0.10 (+1.27%)

At close: Sep 21, 2026, 4:00 PM ET

$7.86

-$0.12 (-1.55%)

Pre-market: Sep 22, 2026, 4:52 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.27%

(1D)

Rating

Updated: Sep 1, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $521.29M

1D Range

7.67 8.13

52W Range

5.37 17.58

Valuation (TTM)

PE -1.59

PB 1.24

EV/EBITDA -2.98

Valuation (NTM)

Forward PE N/A

Forward PEG 0.08

Price Target $5

Cash Flow

FCF Yield -36.8%

SBC Adj. FCF Yield -48.8%

SBC Impact -32.5%

Margins

Gross Margin 80.1%

Operating Margin -259.9%

FCF Margin -171.6%

Growth (CAGR)

Revenue 3Y | 5Y -30.0% | -3.4%

Dil EPS 3Y | 5Y 67.5% | 62.1%

FCF 3Y | 5Y 28.5% | 11.3%

Returns

ROA -29.4%

ROE -60.2%

ROIC -31.6%

Financial Health

Net Cash

$302.16M

Current Ratio 4.57

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The co...

Sector Healthcare

Industry Biotechnology

Employees 485

IPO Date Apr 18, 2021

Website www.ginkgo.bio

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Downside

-37.34%

Buy (0)

Hold (1)

Sell (1)

Analyst Details ➞